Recorded Chinese product: 硫酸卡那霉素片硫酸卡那霉素片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 华润三九(北京)药业有限公司Chinese legal name: 华润三九(北京药业有限公司)
主要成分Active Ingredients
- 卡那霉素DKana Meisu
药物知识说明
卡那霉素D是一种在国家药监局注册认定的药品。该药品含有卡那霉素d-64081075等成分。
该药品关联的活性成分包括：卡那霉素d。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：华润三九(北京)药业有限公司Chinese legal name: 华润三九(北京药业有限公司)。
您可以探索含有相同成分的其他药品：卡那霉素d-64081075成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 硫酸卡那霉素片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Manufacturers recorded for this product: 华润三九(北京)药业有限公司Chinese legal name: 华润三九(北京药业有限公司).
Explore other medicines containing the same ingredient: 卡那霉素d productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 硫酸卡那霉素片Recorded Chinese product: 硫酸卡那霉素片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.125g(12.5万单位)Recorded Chinese specification
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 华润三九(北京)药业有限公司Chinese legal name: 华润三九(北京药业有限公司)
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H11021808
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H11021808
Manufacturer
Chinese legal name: 华润三九(北京)药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H11021808
生产企业
华润三九(北京)药业有限公司(国产)
适应症
本品抗感染药。适用于治疗敏感革兰阴性杆菌所致的严重感染，如细菌性痢疾、肠炎等。亦可用于腹部手术前清洁肠腔。
用法用量
口服给药：
1.成人：
(1)抗感染治疗:一次0.7.～1.25g(75万～125万单位)，一日3～4次。
(2)用于腹部术前准备:一次1g(100万单位)，一小时1次，服4次后改为6小时1次，连服36～72小时。
2.儿童抗感染治疗：每日25～50mg(2.5万～5万单位)/kg，分4次服用。
不良反应
1. 可发生胃肠道反应如:恶心、腹泻等。2. 有患儿使用后导致不可逆听力减退和听力丧失的报道。
禁忌
对本品或其他氨基糖苷类药物有过敏史者禁用。
注意事项
1. 长期或超量服用，有可能引起蛋白尿、管型尿及不可逆听力减退。2. 肾功能不全者慎用，服用多日后血药浓度可能达中毒水平。3. 胃肠溃疡者慎用，因为会促进全身性的吸收。
贮藏
密封，置阴凉处。
规格
0.125g(12.5万单位)
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.